Partners
Circassia is supported by a number of highly respected investors, and employs a proven out-sourcing business model, working closely with a range of world-class life science companies and service providers.
Imperial Innovations
Circassia's lead investor is Imperial Innovations the technology transfer and commercialisation company based at Imperial College London. Please visit www.imperialinnovations.co.uk for more information.
Pharm-Olam
Pharm-Olam International is a multi-national contract research organisation offering a wide range of comprehensive, clinical research services to the pharmaceutical, biotechnology and medical device industries. For more information please visit www.pharm-olam.com.
Nova Laboratories
Nova Laboratories is a UK and International Pharmaceutical Aseptic Contract Manufacturing company, and is a key member of Circassia's out-sourced pharmaceutical development team.
PriceWaterhouseCoopers
PriceWaterhouseCoopers are the Company's auditors.
Did you know?
10% of Americans are allergic to ragweed